Advanced retinoblastoma treatment: targeting hypoxia by inhibition of the mammalian target of rapamycin (mTOR) in LHBETATAG retinal tumors
Y Piña1, C Decatur1, TG Murray1, SK Houston1, D Gologorsky1, M Cavalcante1, L Cavalcante1, E Hernandez1, M Celdran1, W Feuer1, T Lampidis21Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA; 2Department of Cell Biology and Anatomy, University of...
Main Authors: | Y Piña, C Decatur, TG Murray, et al |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2011-03-01
|
Series: | Clinical Ophthalmology |
Online Access: | http://www.dovepress.com/advanced-retinoblastoma-treatment-targeting-hypoxia-by-inhibition-of-t-a6583 |
Similar Items
-
Retinoblastoma treatment: impact of the glycolytic inhibitor 2-deoxy-d-glucose on molecular genomics expression in LHBETATAG retinal tumors
by: Piña Y, et al.
Published: (2012-05-01) -
Novel retinoblastoma treatment avoids chemotherapy: the effect of optimally timed combination therapy with angiogenic and glycolytic inhibitors on LHBETATAG retinoblastoma tumors
by: Samuel K Houston, et al.
Published: (2011-01-01) -
Inhibition of mammalian target of rapamycin (mTOR) in epidermis
by: Sully, Katherine L.
Published: (2012) -
Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration
by: Henry Querfurth, et al.
Published: (2021-07-01) -
The Role of the Mammalian Target of Rapamycin (mTOR) in Pulmonary Fibrosis
by: Jessica Lawrence, et al.
Published: (2018-03-01)